Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
After years of viral “Karen moments,” the internet appears to be officially retiring one of its most infamous labels, and Gen Z is already whispering a replacement. According to social media discourse ...
Bitcoin trades around $87k–$88k, down roughly 0.3% over 24 hours and about 3% over the last week. The intraday band sits near $86,800–$90,200, with 24-hour turnover around $45–49 billion and a monthly ...
Samsung Brain Health Feature Could Show the Early Warning Signs of Dementia The feature would analyze data such as gait patterns, changes in the user’s voice, and various sleep metrics to detect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results